$2.17
-0.26-10.7%
al cierre: Nov 19, 4:00 PM EST
$2.16
-0.27-11.11%
Premercado: 8:02 AM EST

Nautilus Biotechnology (NAUT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Oct 27, 2026 | $-0.12 | $-0.14 | 14.3 % |
| Q2 | Jul 28, 2026 | $-0.11 | $-0.14 | 21.4 % |
| Q1 | Apr 28, 2026 | $-0.12 | $-0.14 | 14.3 % |
| Q4 | Feb 26, 2026 | $-0.11 | $-0.14 | 21.4 % |
Quarterly Revenue (Billions)
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | Oct 27, 2026 | $200.00K | $205.00K | -2.44 % |
| Q1 | May 3, 2022 | $0 | $170.00K | -100.0 % |
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.14 | $-0.14 | $-0.14 | $-0.14 |
| Actual | $-0.12 | $-0.11 | $-0.12 | $-0.11 |
| Surprise | +14.3% | +21.4% | +14.3% | +21.4% |
| Revenue | ||||
| Estimate | $205000 | — | — | — |
| Actual | $200000 | $190000 | $0 | $0 |
| Surprise | -2.44% | — | — | — |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.14 | $-0.13 | $-0.12 | $-0.13 |
| Revenue | ||||
| Consensus | $270000 | $390000 | — | — |